• +91 40 6608 6608
  • info@vivimedlabs.com
  • Live stock info at NSE
  • Live stock info at BSE
  • Login
VivimedlabsVivimedlabs

Welcome to Vivimedlabs

  • Home
  • About
    • Our Company
    • Who We are
    • Vision & Mission
    • Values
    • Management
    • Board of Directors
    • Code of Conduct
  • Business Portfolio
    • Business Model
    • Active Pharmaceutical Ingredients
    • Finished Dosage Formulations
    • R&D
  • Facilities
    • Operational Units
    • Our Accreditations
    • Dosage Forms
  • Product List
  • Investors
    • Financials
    • Corporate Governance
    • Annual Reports
    • Shareholders Information
    • CSR
    • Other Data
  • News & Events
    • Awards & Achievements
  • Contact Us
    • Careers
    • Contact Us

News & Events

Vivimedlabs   →  News & Events

News & Events

Vivimed Launches its own brand of favipiravir, Favulous

Hyderabad, India, August 5, 2020 - Vivimed Labs Limited ("Vivimed" or the Company), a niche Specialty Chemicals
Read More

2018- acquisition of Soneas, a CDMO based out of Budapest, Hungary.

Hyderabad, India, May 16, 2018- Vivimed Labs Spain S.L, the parent of UQUIFA
Read More

Orbimed Asia invests in UQUIFA, the API entity of Vivimed Labs

Hyderabad, lndia, september 25,2017 - Vivimed Labs Limited
Read More
Established in 1991 in Hyderabad, India, Vivimed Labs has metamorphosed from a domestic small, entrepreneurial family-operated Readmore

About

  • Our Company
  • Who We are
  • Vision & Mission
  • Values
  • Management
  • Board of Directors
  • Code of Conduct

Business Portfolio

  • Business Model
  • Active Pharmaceutical Ingredients
  • Finished Dosage Formulations
  • R&D

Investors

  • Financials
  • Corporate Governance
  • Annual Reports
  • Shareholders Information
  • CSR
  • Other Data
© Copyright 2016-2020. All Rights Reserved

Powered by Sqenta